Effect of blocking CD96 on CD8+T cell-mediated elimination of tumor dormancy

被引：0
|
作者：
Wang, Hongye [1 ]
Geng, Haigang [1 ]
Wu, Zhaorong [1 ]
Zhong, Yiqing [1 ]
Song, Zhenyu [1 ]
Bian, Linke [1 ]
Cui, Dan [1 ]
Zhai, Bo [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14679
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Epigenetic mechanisms in LSEC mediated CD8+T cell tolerance
    Boettcher, J.
    Diehl, L.
    Knolle, P. A.
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 : 125 - 125
  • [32] AXL receptor tyrosine kinase inhibition improves the anti-tumor effects of CD8+T cells by inducing CD103+dendritic cell-mediated T cell priming
    Im, Kyungtaek
    Choi, Yun Jung
    Kim, Dong Ha
    Kim, Da -Som
    Ban, Kyosun
    Ji, Wonjun
    Baek, In-Jeoung
    Choi, Chang-Min
    Lee, Jae Cheol
    Rho, Jin Kyung
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 680 : 7 - 14
  • [33] Imaging CD8+T cell tumor infiltration following radiotherapy
    Wierstra, P.
    Raave, R.
    Sandker, G.
    Boswinkel, M.
    Molkenboer-Kuenen, J.
    Adema, G.
    Bussink, J.
    Gotthardt, M.
    Aarntzen, E.
    Heskamp, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S191 - S192
  • [34] YAP Attenuates CD8 T Cell-Mediated Anti-tumor Response
    Lebid, Andriana
    Chung, Liam
    Pardoll, Drew M.
    Pan, Fan
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [35] Loss of CD96 Expression as a Marker of HIV-Specific CD8+ T-Cell Differentiation and Dysfunction
    Bunet, Remi
    Nayrac, Manon
    Ramani, Hardik
    Sylla, Mohamed
    Durand, Madeleine
    Chartrand-Lefebvre, Carl
    Routy, Jean-Pierre
    Landay, Alan L.
    Gauchat, Jean-Francois
    Chomont, Nicolas
    Ancuta, Petronela
    Kaufmann, Daniel E.
    Bernard, Nicole
    Tremblay, Cecile L.
    El-Far, Mohamed
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [36] CD96 functions as a co-stimulatory receptor to enhance CD8+ T cell activation and effector responses
    Chiang, Eugene Y.
    de Almeida, Patricia E.
    de Almeida Nagata, Denise E.
    Bowles, Kristin Harden
    Du, Xiangnan
    Chitre, Avantika S.
    Banta, Karl L.
    Kwon, Youngsu
    McKenzie, Brent
    Mittman, Stephanie
    Cubas, Rafael
    Anderson, Keith R.
    Warming, Soren
    Grogan, Jane L.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2020, 50 (06) : 891 - 902
  • [37] Low-dose interleukin-2 treatment inhibits follicular cytotoxic CD8+T cells and deteriorates CD8+T cell-mediated immunopathology during viral infection
    Zhou, P.
    Chen, Y.
    Zheng, T.
    Yu, D.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1021 - 1021
  • [38] Drug-Loaded Tumor-Derived Microparticles Elicit CD8+T Cell-Mediated Anti-Tumor Response in Hepatocellular Carcinoma
    Chen, Yulin
    Zhang, Yi
    Wang, Jianjun
    Cai, Xiong
    Chen, Junzhang
    Min, Xiaobo
    Xu, Yunjie
    Qin, Qi
    Wan, Chidan
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2024, 19 : 2227 - 2239
  • [39] Regulation of tumor dormancy by CD4(+) and CD8(+) T cell subpopulations.
    Farrar, JD
    Katz, KS
    Windsor, JL
    Uhr, JW
    Street, NE
    FASEB JOURNAL, 1996, 10 (06): : 2556 - 2556
  • [40] MICROBIAL SHORT-CHAIN FATTY ACIDS ENHANCE CD8+T CELL-MEDIATED CANCER IMMUNOTHERAPY
    Luu, M.
    Riester, Z.
    Danhof, S.
    Nerreter, T.
    Mulder, I.
    Visekruna, A.
    Hudecek, M.
    HUMAN GENE THERAPY, 2022, 33 (7-8) : A37 - A37
12345